menu
cancel
A peptide can produce a clean-looking chromatogram and still fail a completely different quality question.
That is the central distinction between purity and sterility. Purity testing examines the chemical profile seen by a defined analytical method. Sterility testing looks for viable microorganisms under defined microbiological test conditions. One result cannot substitute for the other.
This matters because a large purity number often travels farther than its meaning. A certificate may show 98 or 99 percent purity, and readers may take that as evidence that the material is clean in every relevant sense. It is not. The percentage says something about the signals detected and measured by that method. It does not show that the material is sterile, free of endotoxin, correctly identified, accurately filled, stable, or protected by an intact container.
Good quality evaluation starts by asking one question per test: What was the method designed to detect, and what remains outside its field of view?
Purity is primarily a chemical question. Sterility is a microbiological question.
A chromatographic purity test separates detectable components according to their physicochemical behavior and reports a result using a defined procedure. That procedure must be suitable for its intended purpose, including the impurities and concentration range it is expected to measure.
A sterility test places selected samples into conditions intended to reveal viable microbial growth. USP General Chapter 71 describes the compendial sterility test, while FDA guidance explains that finished-product sterility testing has limited sensitivity because only a sample of the batch is tested.
The tests can both belong in a quality program, but they answer different questions. A strong result from one leaves the other unanswered.
The simplest way to avoid confusion is to compare the question, sample, method, result, and limits of each test.
Chromatography separates components because they interact differently with a stationary phase and a mobile phase. HPLC is one of the chromatographic techniques used for qualitative and quantitative analysis.
In a peptide purity method, the main peak may represent the target peptide and smaller peaks may represent related substances, byproducts, or degradation products that the method can separate and detect. The reported percentage is often based on integrated peak areas. It is therefore a result produced by a specific detector, wavelength, column, mobile phase, gradient, integration approach, and reporting threshold.
That last sentence is the part marketing language tends to lose. A chromatogram is not a universal contamination scanner. It shows what the method is capable of showing.
ICH Q2(R2) treats identity, impurity or purity, and assay as different analytical uses. It also requires an analytical procedure to be validated for its intended purpose. Specificity, range, accuracy, precision, and detection capability matter because a result is only as meaningful as the procedure behind it.
ICH Q6A makes the same broader point through specifications. Product quality is established through a list of tests, analytical procedures, and acceptance criteria. No single test supplies complete characterization or answers every quality question.
A high chromatographic purity result may support a conclusion about the relative chemical profile measured by that method. It does not automatically establish:
Some of those questions require other analytical methods. Others require microbiological testing, manufacturing records, process validation, environmental data, or package integrity work.
Sterility testing is designed to determine whether the tested article complies with a sterility requirement under the specified method. In practical terms, selected samples are exposed to culture conditions intended to reveal viable microbial growth.
A passing result means growth was not detected in the tested units under the test conditions. It should not be rewritten as proof that every unit in the batch contains zero microorganisms.
FDA illustrates the sampling limit with a direct example. If 20 units are tested from a 10,000-unit batch that contains contamination in 0.1 percent of units, the batch still has a 98 percent chance of passing the sterility test. The numbers are not an argument against testing. They explain why testing alone cannot carry the entire sterility claim.
A positive sterility result is serious because it may reveal a product, process, or laboratory problem. A negative result is only one part of the evidence. The manufacturing process must do most of the work.
FDA describes current good manufacturing practice as minimum requirements for the methods, facilities, and controls used to manufacture, process, and pack a drug product.
For sterile products, quality is designed into facilities, equipment, materials, procedures, personnel practices, and the package. FDA's aseptic processing guidance describes a control system that includes cleanroom design, equipment qualification, sterilization, process simulations, environmental monitoring, laboratory controls, and review of production records.
A media fill challenges the aseptic process using microbiological growth medium in place of product. Environmental monitoring looks for microbial and particle trends in the areas where sterile operations occur. Container closure integrity helps determine whether the package can protect the product after filling. These controls answer questions that a final chromatogram cannot reach.
This is why a sterility claim should be connected to more than a line on a certificate. The evidence should make sense as a system: validated processes, controlled environments, meaningful sampling, suitable microbiological methods, investigated deviations, and a package that maintains its barrier.
The laboratory does not open and test every finished unit. Doing so would destroy the batch. Instead, a defined sampling plan selects units that should represent the operation, including relevant points across the filling run and any unusual interventions or events. [5]
Sampling creates an unavoidable limit. Low-level, uneven contamination may be missed. That is why the history of the process and the conditions under which the batch was produced matter so much.
Sterility and endotoxin are also separate questions.
A sterility test is designed to reveal viable microorganisms under defined growth conditions. A bacterial endotoxins test evaluates endotoxin using a different analytical principle. FDA addresses endotoxin testing through separate guidance and points to USP Chapter 85 for the compendial bacterial endotoxins test. [8]
A sample can show no viable microbial growth and still require independent endotoxin evaluation. A purity chromatogram does not replace either test. The three results belong to different parts of the quality picture.
Quality attributes do not rise and fall together. A material may produce one reassuring result while another attribute remains unknown or unacceptable.
A certificate of analysis becomes more useful when each line is treated as a separate question. Do not let the most impressive number cast a halo over the rest of the document.
These questions do not ask a single result to become perfect. They ask the evidence to stay within its proper scope.
A red flag is a reason to ask for the missing evidence. It is not a substitute for an investigation or a final judgment.
A clean chromatogram can be meaningful. It can show that a defined chemical method found a profile that met a stated purity criterion. That is valuable information when the method, sample, and specification are clear.
It cannot establish sterility because sterility is a different attribute, measured through different methods and supported by a different control system. The same boundary applies to endotoxin, identity, assay, stability, particulates, and package integrity.
The disciplined reading is straightforward. Let each test answer its own question. Then ask whether the full set of evidence matches the claim being made.
A quality result becomes trustworthy when its limits are as clear as its number.
This article is for general educational and informational purposes only. It does not constitute medical, laboratory, manufacturing, quality, regulatory, diagnostic, or treatment advice.
Test results apply to the specific sample, method, specification, laboratory, batch, and conditions reported. No individual test establishes the complete quality, safety, sterility, identity, purity, strength, stability, or suitability of a material or product.
Do not use this article to select, obtain, prepare, test, release, dose, combine, administer, or discontinue any product or treatment. Consult qualified medical, scientific, laboratory, manufacturing, quality, and regulatory professionals for decisions in those areas.